CBLL - Kewajiban jangka dawa marang modal ceribell.com

Tandha merek CeriBell EEG (CBLL)

This price chart, serving as confirmation of the market valuation, demonstrates the price action of CeriBell, Inc. (CBLL), which generates revenue from the sale and leasing of AI systems for brain activity monitoring and EEG headsets. The long-term debt-to-equity ratio stands at 0.16. Management is effectively scaling the equipment fleet across US intensive care units, ensuring transparent growth. Meanwhile, the company adheres to basic eco-compliance by optimizing cloud computing and office processes.

CBLL - Utang jangka dawa marang ekuitas CeriBell Inc ing rentang 12.10.2024 - 28.10.2026
Barang utama CeriBell

Transparency of the financing structure is critical for conservative investors to assess business resilience against market shocks. This long-term debt-to-equity ratio measures the proportion of long-term liabilities relative to equity, determining the degree of financial leverage and the risk of insolvency. For CeriBell, Inc. (CBLL), which is developing cloud-based rapid EEG for intensive care units, this balance reveals the extent to which the technological platform's expansion relies on borrowed funds.

Analisis pesaing

Rasio utang jangka dawa marang modal Biogen Inc|Neurocrine Biosciences Inc - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Regencell Corp RGC|Rasio utang jangka dawa marang ekuitas AXSM (Axsome Therapeutics)|acadia-pharm.com - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Xenon (XENE)|VKTX: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas SUPN|Catalyst Corp (CPRX) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal DNLI|Rasio utang jangka dawa marang ekuitas harmonybiosciences.com|Biohaven - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal AMLX (Amylyx Pharmaceuticals Inc)|Utang jangka dawa marang ekuitas Trevi Pharma|Koefisien utang jangka dawa marang modal Praxis Corp PRAX|Utang jangka dawa marang modal AVXL (Anavex Life Sciences)|PRTA - Rasio tanggungan utang jangka dawa marang modal|alector.com (ALEC) - Utang jangka dawa marang modal|Annexon Biosciences (ANNX) - Utang jangka dawa marang ekuitas|Utang jangka dawa marang modal OMER (Omeros Corp)|Kewajiban jangka dawa marang modal NGNE|Utang jangka dawa marang ekuitas AC Immune (ACIU)|Utang jangka dawa marang ekuitas VYGR (voyagertherapeutics.com)|Utang jangka dawa marang ekuitas Neumora Therapeutics, Inc. NMRA|SCLX - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Tevogen Bio Holdings, Inc. (TVGN)|ACOG - Koefisien utang jangka dawa marang modal|Cognition Therapeutics - Utang jangka dawa marang modal|IKT (inhibikase.com) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Cassava Sciences (SAVA)|Rasio utang jangka dawa marang modal Assertio Therapeutics|Utang jangka dawa marang modal COYA (Coya Therapeutics, Inc.)|Rasio utang jangka dawa marang ekuitas vistagen.com VTGN|Rasio utang jangka dawa marang ekuitas OVID|Rasio tanggungan utang jangka dawa marang modal acumenpharm.com ABOS|CRVO: Utang jangka dawa marang modal|ATHE - Rasio utang jangka dawa marang ekuitas|clene.com (CLNN) - Utang jangka dawa marang modal|PEPG (PepGen) - Utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Jupiter Neurosciences Inc|Utang jangka dawa marang ekuitas RLMD|Utang jangka dawa marang ekuitas Annovis Bio (ANVS)|Utang jangka dawa marang ekuitas GRCE (gracetx.com)|AIFF - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal ANEW Medical KLTO|NRSN (NeuroSense Therapeutics, Ltd.) - Utang jangka dawa marang modal|revivapharma.com (RVPH) - Kewajiban jangka dawa marang modal|MTVA: Rasio utang jangka dawa marang ekuitas|NRXS (NeurAxis Inc.) - Utang jangka dawa marang modal|HSDT - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PASG|Neuphoria Therapeutics Inc. - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal minervaneurosciences.com (NERV)|Athira Pharma - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Addex Therapeutics Ltd. ADXN|ALZN (Alzamend) - Utang jangka dawa marang modal|CYCN: Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas protagenic.com PTIX|Pasithea Therapeutics Corp. (KTTA) - Koefisien utang jangka dawa marang modal|CRGT: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Avenue Therapeutics Inc.|Utang jangka dawa marang modal Brainstorm Cell Therapeutics, Inc. (BCLI)|Utang jangka dawa marang ekuitas Cara Therapeutics Inc (CARA)|CHRO: Utang jangka dawa marang modal|Eliem Therapeutics, Inc. - Kewajiban jangka dawa marang modal|ITCI - Utang jangka dawa marang ekuitas|LBPH: Utang jangka dawa marang ekuitas|Marinus (MRNS) - Utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas NKGen Biotech Corp|NRBO - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal sagerx.com|SNPX (Synaptogenix) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal TRVN (Trevena Inc.)|VIGL - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal Anew Medical Inc. WENA|CERE: Utang jangka dawa marang modal